An 'Electronic Nose' Reads Stool Gases to Flag Colorectal Cancer

A full laboratory analysis of stool gases is powerful but slow and expensive. This study asked a more practical question: could a compact sensor device — an “electronic nose” that recognizes overall gas patterns rather than identifying each molecule — pick up the same signals?

What the researchers did

The team collected stool samples from 157 people: 40 with confirmed colorectal cancer, 60 with advanced adenomas (pre-cancerous growths), and 57 healthy volunteers with a clear colonoscopy. They analyzed the gas above each sample with an electronic nose and used pattern-recognition software to see whether the device could tell the groups apart.

What they found

• Cancer versus healthy: the device separated the groups with high accuracy (AUC 0.92, with 85% sensitivity and 87% specificity).
• Pre-cancerous growths versus healthy: it also detected a difference at the earlier adenoma stage, though less strongly (AUC 0.79).
• The device worked by recognizing the overall gas “smellprint,” without identifying any single compound.

“The electronic nose was able to distinguish patients with colorectal neoplasia from controls by analysis of fecal volatile biomarker patterns, supporting the concept of a non-invasive, stool-based screening tool.”

This is published research shared for education, not medical advice — no consumer product diagnoses cancer. The broader lesson for gut health is striking: the gut’s gas signature carries enough information that even a relatively simple sensor can detect meaningful patterns, and those patterns shift gradually as gut conditions change.